Newsletter > Letter n°4

grey   9th EDITION (2013) grey June 10/12th, 2013   grey  
Abstract submission before April, 15thNanoBioEurope2013

June, 10/12th 2013

Following the success of abstract submission and many requests to submit abstract past the last minute we have decided to extend submission deadline to April, 15th.
To download the abstract template and submit click HERE


Monday, 11th Tuesday, 12th Wednesday, 13th
Welcome Imaging based nanotechnology Nano-Oncology & Nanomedicine
Single molecule technology Nano-objects & nanomaterial for life sciences Nanotoxicity
Lunch Lunch Lunch
Sensing based nanotechnology Nano-enabled drug delivery CGSO & CLARA session
Young scientists flash talks Industrial Innovation flash talks
Poster session Nanotechnology for cell characterisation & tissue engineering
Gala Evening at the Museum End
*This synthetic pre-programme does not display coffee breaks and is subject to minor changes.

point FOCUS ON... InNaBioSanté Foundation

InNaBioSanté foundationThe medical research of tomorrow will require new and different cross-disciplinary cooperation. It will also need partnerships that cross borders, cultures, sciences and knowledge.

The InNaBioSanté Foundation was created in 2006 by five companies involved in research and development of new technologies (Amgen, GSK, Pierre Fabre, Siemens, Total) and with the participation of the French National Research Agency (ANR). Its goal is to define, promote and finance excellent, innovative projects that break new ground, building on a scientific foundation that draws on:

  • Nanotechnology,
  • Biotechnology,
  • Information technology,
  • Imaging and radiotherapy techniques.

This convergence of “engineering sciences” in the medical research field, with a special focus in oncology, offers tremendous possibilities of reducing disease by improving the healthcare system – from prevention to treating patients and curing illness.

InNaBioSanté Foundation selects a few very innovative projects to be granted at a high level for average three years duration. InNaBioSanté now focuses his activities for the benefits of the Toulouse Oncopole, especially for the ITAV Laboratories, the Toulouse Cancer Research Center, and the Universitary Cancer Institute, and its international attractiveness.


1. Single molecule technology
Prof. Tom Perkins
JILA, NIST & CU-Boulder, USA
Pulling on single biological molecules: a powerful tool for studying diverse systems
Dr. Jonas Tegenfeldt
Lund University, Sweden
DNA mapping in nanochannels
2. Sensing based nanotechnology
Prof. Guy Voirin
CSEM, Switzerland
Nanomechanical sensors for use in environmental control, security and diagnostics
Prof. Alain Brisson
CBMN, France
Circulating Microvesicles : a new class of disease biomarkers ?
Prof. Anja Boisen
DTU Nanotech, Denmark
Nanomechanical sensors for use in environmental control, security and diagnostics
3. Imaging based nanotechnology
Dr. Tomazo Zambelli
ETH Zürich, Switzerland
FluidFM: combining AFM and microfluidics for single-cell manipulation
Dr. Pierre-Emmanuel Milhiet
CBS, France
New developments in BIo AFM Imaging
4. Nano-objects & nanomaterial for life sciences
Prof. Dr. Martin Bastmeyer
KIT, Germany
Bio-functionalized 3D-scaffolds for cell studies
Prof. Sebastien Lecommandoux
LCPO, France
Biomimetic synthetic glycoprotein-like copolymer nanoparticles for targeted drug delivery
5. Nano-enabled drug delivery
Dr. Gilles Divita
CRBM, France
Peptide-based nanoparticles for targeted drug delivery
Prof. Jean-Christophe Leroux
ETH Zürich, Switzerland
Nanocarriers in medicine : challenges, dogmas and new horizons
Dr. Samir El Andaloussi
Karolinska Institute, Sweden
Biological nanovesicles (exosomes) for macromolecular drug delivery
6. Nanotechnology for cell characterisation & tissue engineering
Prof. Dr. Lino Ferreira
CNCB, Portugal
Nanomaterials to modulate (stem) cell activity
Prof. Dr. Xavier Trepat
Forces, waves, and multiscale dynamics in living tissues
7. Nano-Oncology & Nanomedicine
Dr. François Berger
Clinatec, France
New challenges for nanomedicine
Dr. Paul Galvin
Tyndall Institute, Ireland
Nano-enabled personalised medicine
8. Nanotoxicity
Prof. Dr. Rafi Korenstein
Tel-Aviv University, Israel
Current challenges of nanotoxicology
Dr. François Rossi
JRC Ispra, Italy
In vitro Toxicity testing of manufactured nanomaterials: an experimental challenge

point According to its main objectives, NBE is going to grant industrial visibility through flash talks, stands, datings with interested researchers...

3 different levels of partner opportunities can be allowed. From the gold one which is unique to the bronze which is more linked to an industrial stand and an opportunity to join a page in the abstract book. But a partnership is built by discussion. Until we are able to know how each partner can bring its mastership, its own identity and how can we help you to succeed in it. For exemple a sponsor can promote and help the best student presentations, both oral one or poster…


  • to schedule Abstract submission deadline :
    April, 15th, 2013
  • Partners package available until:
    May, 12th, 2013
  • Early rate registration deadline:
    May, 12th, 2013
point NBE 2013 THANKS TO...

Our institutionnal Partners

CNRS Région Midi-Pyréénes

And with the collaboration of...

Follow us on Twitter
To ensure our newsletter always reaches your inbox, please add to your address book.
If you prefer not to receive news from NBE2013 in the future ( 3 mails max ), you can unsubscribe here

subscribe unsubscribe website

Online user: 1